AQR Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-980,971
Closed -$97.4M 2252
2019
Q3
$97.4M Sell
980,971
-54,567
-5% -$5.18M 0.11% 215
2019
Q2
$95.7M Buy
1,035,538
+10,022
+1% +$952K 0.11% 226
2019
Q1
$96.7M Sell
1,025,516
-5,661,663
-85% -$495M 0.1% 233
2018
Q4
$429M Buy
6,687,179
+2,596,834
+63% +$192M 0.5% 49
2018
Q3
$366M Buy
4,090,345
+1,143,027
+39% +$101M 0.35% 67
2018
Q2
$234M Sell
2,947,318
-3,152,880
-52% -$262M 0.24% 113
2018
Q1
$545M Buy
6,100,198
+1,721,662
+39% +$165M 0.59% 31
2017
Q4
$457M Buy
4,378,536
+2,378,345
+119% +$268M 0.48% 42
2017
Q3
$292M Buy
2,000,191
+1,142,163
+133% +$156M 0.35% 72
2017
Q2
$111M Sell
858,028
-53,516
-6% -$6.56M 0.15% 184
2017
Q1
$113M Buy
911,544
+333,820
+58% +$39.9M 0.15% 188
2016
Q4
$66.9M Buy
577,724
+90,646
+19% +$10.1M 0.09% 299
2016
Q3
$50.9M Buy
487,078
+321,792
+195% +$34.8M 0.08% 343
2016
Q2
$16.3M Buy
165,286
+66,978
+68% +$6.93M 0.03% 596
2016
Q1
$9.84M Sell
98,308
-668,830
-87% -$68.9M 0.02% 691
2015
Q4
$91.9M Sell
767,138
-769,476
-50% -$89M 0.16% 171
2015
Q3
$166M Buy
1,536,614
+12,915
+0.8% +$1.6M 0.33% 70
2015
Q2
$176M Buy
1,523,699
+259,377
+21% +$29.7M 0.35% 61
2015
Q1
$146M Buy
1,264,322
+88,569
+8% +$10.6M 0.33% 76
2014
Q4
$132M Buy
1,175,753
+65,424
+6% +$6.9M 0.28% 98
2014
Q3
$105M Sell
1,110,329
-1,179,489
-52% -$106M 0.29% 80
2014
Q2
$197M Sell
2,289,818
-274,000
-11% -$20.8M 0.53% 24
2014
Q1
$179M Sell
2,563,818
-185,400
-7% -$14.7M 0.54% 28
2013
Q4
$232M Buy
2,749,218
+442,244
+19% +$35M 0.69% 11
2013
Q3
$178M Buy
2,306,974
+351,212
+18% +$24.6M 0.63% 14
2013
Q2
$114M Buy
+1,955,762
New +$118M 0.41% 44

Other funds holding CELG

AQR Capital Management's CELG Position: Q4 2019 in Review

AQR Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 980,971 shares — an estimated $97.4M sold.

AQR Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $545M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • AQR Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • AQR Capital Management sold 980,971 Celgene Corp shares in Q4 2019, an estimated $97.4M.
  • AQR Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • AQR Capital Management's Celgene Corp position peaked at $545M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.